Vendor Intelligence Report: Peptide Technologies

Published 13 Jun 2026. 23-page investigative report on who is behind Peptide Technologies: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 3 pages are free to read on this page.

Peptide Technologies shows a 64% Finnrick pass rate across 11 tests, with semaglutide comparatively stronger, PT-141 mixed, and BPC-157 the main weak point. The report traces a MATCH-listing payment…